|
|
|
| Clinical Observation on the Treatment of Allergic Purpura Nephritis with Yangyin Zhixue Formula Combined with Traditional Chinese Medicine Acupoint Application |
| Yang Yumeng1, Wang Ke2, Zhang Chunjian2, Xie Junxia2,* |
1. Heilongjiang Academy of Traditional Chinese Medicine,Heilongjiang Province,Harbin 150000,China;
2. Hanan Hospital,the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine,Heilongjiang Province,Harbin 150000,China |
|
|
|
|
Abstract Objective To discuss the clinical effect of Yangyin Zhixue Decoction combined with acupoint application of traditional Chinese medicine in the treatment of allergic purpura nephritis.Methods Sixty sick persons with allergic purpura nephritis were selected and separated into two groups according to the random number table：the nourishing yin and hemostatic formula group（30 cases）and the treatment group（30 cases）.The levels of serum TNF-α,IL-8,serum creatinine（SCr）,high-sensitivity C-reactive protein（hs-CRP）,24-hour urinary protein and urinary RBC count were measured before and after treatment.Results The entirely effective rate of the treatment group was 95.0%,and the effective rate of the Yangyin Zhixue Decoction group was 90.0 %.There was a major difference between the two groups（P<0.05）.In terms of reducing urinary protein and urinary red blood cells,there were major differences between the two groups before and after treatment（P<0.05）.The level of TNF-α in the serum of the two groups after treatment was inferior to before treatment（P<0.05）,and the contrast between the two groups（P<0.05）;the serum levels of IL-8 and C-reactive protein in the two groups were lower than those before treatment（P<0.05）,and there was no obvious difference between the two groups（P>0.05）.Conclusion The combination of Yangyin Zhixue Formula and traditional Chinese medicine acupoint application is superior to the single use of Yangyin Zhixue Formula in improving clinical symptoms,reducing urinary protein,and reducing red blood cells in patients with purpura,which may protect renal function by regulating immune imbalance in patients with purpura.
|
|
Received: 25 May 2024
|
|
|
|
|
|
[1] 王庆谊,孟昭影.过敏性紫癜发病机制的研究进展[J].中国中西医结合皮肤性病学杂志,2020,19(03):285-287.
[2] 沈小雄,肖小妹,朱云霏等.过敏性紫癜肾损害的早期诊断[J].赣南医学院学报,2018,38(02):195-199.
[3] 闫星域,夏运风.过敏性紫癜性肾炎的治疗进展[J].医学综述,2020,26(20):4088-4092.
[4] 王晖,宋立群.中医药治疗过敏性紫癜性肾炎的研究进展[J].中华中医药杂志,2023,38(03):1180-1184.
[5] 马岩波. 过敏性紫癜性肾炎患儿IgG亚类水平及其与肾功能的关系探讨[J].中国中西医结合肾病杂志,2023,24(02):134-136.
[6] 张李博,任雄飞,郭婷婷等.孙郁芝治疗过敏性紫癜性肾炎经验[J].时珍国医国药,2021,32(10):2561-2562.
[7] 师小萌,王月美,边莉等.中医临床辨证施治成人过敏性紫癜性肾炎疗效及对血EGF、PAF-AH表达的影响[J].现代中西医结合杂志,2021,30(33):3711-3714+3752.
[8] 许琳洁,刘文军.过敏性紫癜性肾炎方药规律及中医证候分析[J].世界中医药,2020,15(16):2490-2493+2498.
[9] 田洪民,王淑屏,王鸿雁.过敏性紫癜患儿及紫癜性肾炎患儿血清炎症因子水平变化及意义[J].中国临床药理学杂志,2020,36(15):2189-2192. |
| [1] |
. [J]. journal1, 2023, 43(3): 126-128. |
| [2] |
. [J]. journal1, 2022, 42(4): 118-119. |
| [3] |
. [J]. journal1, 2021, 41(5): 139-140. |
|
|
|
|
2024, Vol. 44 
